🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is study is to evaluate the safety and efficacy of cosibelimab in spec...
Status
Recruiting
Location
Brigham and Women's Hospital
Start Date
2026-04-23
Trial ID
NCT07426484
Treatments Being Tested
Phase 1 open label, multi-center, dose-escalation study for individuals wit...
Status
Terminated
Location
TG Therapeutics Investigational Trial Site
Start Date
2019-04-17
Trial ID
NCT03778073
CK-301 (cosibelimab) is a fully human monoclonal antibody of IgG1 subtype t...
Status
Active Not Recruiting
Location
Research Site
Start Date
2017-09-20
Trial ID
NCT03212404
Treatments Being Tested
This is an efficacy and safety study of cosibelimab (CK-301) combined with ...
Status
Terminated
Location
Research Site
Start Date
2021-12-08
Trial ID
NCT04786964
This is a single-center, open-label, phase 1 dose escalation and dose expan...
Status
Not Yet Recruiting
Location
Cedars-Sinai Cancer at SOCC
Start Date
2026-01
Trial ID
NCT06981806
Treatments Being Tested